IJMPD | Evaluation of pregnancy outcomes after thyroid surgery

Indexing and Abstracting

Evaluation of pregnancy outcomes after thyroid surgery

Mohammed Tareq Mohammed , Ahmed Fakhri Omar , Muna Kadhum Farhood Malla , Ali Qais Abdulkafi

International Journal of Medical, Pharmacy and Drug Research(IJMPD), Vol-7,Issue-4, July - September 2023, Pages 1-5 , 10.22161/ijmpd.7.4.1

Download | Downloads : 3 | Total View : 416

Article Info: Received: 03 Jun 2023; Received in revised form: 05 Jul 2023; Accepted: 13 Jul 2023; Available online: 20 Jun 2023

Abstract:

Background: According to contemporary cancer data, women account for roughly 75% of differentiated thyroid carcinoma (DTC), with the largest incidence occurring in individuals aged 50-59 years in the United States. Objective: This paper aims to evaluate of pregnancy outcomes after thyroid surgery. Patients and methods: This paper was interested to analyse and evaluate of pregnancy outcomes after thyroid surgery by radioactive iodine therapy, which includes 42 cases of pregnant women which suffered of thyroid and processes of thyroid surgery were applied in different hospitals in Iraq from 15th March 2021 to 27th July 2022. This data collected were analysed and conducted all demographic characteristics by the SPSS program. Discussion: This paper was presented different outcomes of pregnant women patients where it presented that the women have overweight were more struggled than those underweight due to a goiter which causes an overweight. In addition, the outcomes of pregnancy outcomes after surgery were got low birth weight; baby were most of the risk factors that have a high influenced on the women after pregnancy, with where it covered 7.1% of women. Furthermore, in the evaluations of blood pressure measurements post-operative of pregnant women surgery where this study diastolic blood pressure of women measurements after surgery and during surgery which found 57.14% for women have a blood pressure of <80 mm Hg and 23.81 for women have 80-89 mm Hg as well as 19.05 for women have >90 mm Hg. Conclusion: In conclusion, this study indicates that there is uncontrolled hyperthyroidism in pregnant patients, which causes many effects. In addition, this study showed that thyroidectomy surgery was successful, but our study found that there is an increased risk in the case of premature delivery before radioactive iodine treatment. After thyroid surgery, radioactive iodine therapy may be required in some thyroid cancer instances. As of currently, this paper suggests women waiting at least six months before getting pregnant after receiving radioactive iodine therapy due to worries about potential radiation impacts on the unborn child's development.

Keywords:

thyroid; hypertension; Overweight; and Surgical treatments.

References:

[1] Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26 (1):1-133.
[2] Wu JX, Young S, Ro K, et al. Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well-differentiated thyroid cancer. Thyroid. 2015;25 (1):133-138.
[3] Sawka AM, Lakra DC, Lea J, et al. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf). 2008;69 (3):479-490.
[4] Sawka AM, Lea J, Alshehri B, et al. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors. Clin Endocrinol (Oxf). 2008;68 (4):610-617.
[5] Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2017;27 (3):315-389.
[6] Luster M, Clarke SE, Dietlein M, et al.; European Association of Nuclear Medicine (EANM). Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008; 35 (10):1941-1959.
[7] World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310 (20):2191-2194.
[8] Seo GH, Cho YY, Chung JH, Kim SW. Increased risk of leukemia after radioactive iodine therapy in patients with thyroid cancer: a nationwide, population-based study in Korea. Thyroid. 2015;25 (8):927-934. doi:10.1089/thy.2014.0557
[9] Molenaar RJ, Sidana S, Radivoyevitch T, et al. Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer. J Clin Oncol. 2018;36 (18):1831-1839.
[10] Rubino C, de Vathaire F, Dottorini ME, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer. 2003;89 (9):1638-1644.
[11] Subramanian S, Goldstein DP, Parlea L, et al. Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid. 2007;17 (12):1277-1288.
[12] Sawka AM, Thabane L, Parlea L, et al. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid. 2009;19 (5):451-457.
[13] Vini L, Hyer S, Al-Saadi A, Pratt B, Harmer C. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J. 2002;78 (916):92-93.
[14] do Rosario PW, Barroso AL, Rezende LL, Padrao EL, Borges MA, Purisch S. Malformations in the offspring of women with thyroid cancer treated with radioiodine for the ablation of thyroid remnants. Arq Bras Endocrinol Metabol. 2006;50 (5):930-933.
[15] Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med. 1995; 36 (1):21-27.
[16] Schlumberger M, De Vathaire F, Ceccarelli C, et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med. 1996;37 (4):606-612.
[17] Chow SM, Yau S, Lee SH, Leung WM, Law SC. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment. Int J Radiat Oncol Biol Phys. 2004;59 (4):992-1000.
[18] Brandao CD, Miranda AE, Correa ND, Sieiro Netto L, Corbo R, Vaisman M. Radioiodine therapy and subsequent pregnancy. Arq Bras Endocrinol Metabol. 2007;51 (4):534-540.
[19] Bal C, Kumar A, Tripathi M, et al. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with a change in female fertility or any genetic risk to the offspring. Int J Radiat Oncol Biol Phys. 2005;63 (2):449-455.
[20] Garsi JP, Schlumberger M, Rubino C, et al. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies. J Nucl Med. 2008;49 (5): 845-852.